in Health 

Galantamine Hydrobromide Powder Uses in Specific Populations

Summary of the dangers There is insufficient information on the developmental risk of RAZADYNE ER or RAZADYNE in pregnant women. At doses comparable to or greater than those used clinically, galantamine administration during pregnancy resulted in developmental toxicity (increased occurrence of morphological defects and reduced growth in offspring) in animal studies (see Data). The estimated history risk of significant congenital disabilities and miscarriage in clinically recognized pregnancies in the general population of the United States is 2-4 percent and 15-20 percent, respectively. For the indicated population, the history risk of…

Read More
Follow by Email